These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 1645153)

  • 21. Parvovirus B19 empty capsids as antigen carriers for presentation of antigenic determinants of dengue 2 virus.
    Amexis G; Young NS
    J Infect Dis; 2006 Sep; 194(6):790-4. PubMed ID: 16941345
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative evaluation of two commercial enzyme immunoassays for serodiagnosis of human parvovirus B19 infection.
    Enders M; Helbig S; Hunjet A; Pfister H; Reichhuber C; Motz M
    J Virol Methods; 2007 Dec; 146(1-2):409-13. PubMed ID: 17854916
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CD4(+) T-cell responses against the VP1-unique region in individuals with recent and persistent parvovirus B19 infection.
    Lindner J; Barabas S; Saar K; Altmann D; Pfister A; Fleck M; Deml L; Modrow S
    J Vet Med B Infect Dis Vet Public Health; 2005; 52(7-8):356-61. PubMed ID: 16316401
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro culture for the detection of infectious human parvovirus B19 and B19-specific antibodies using foetal haematopoietic precursor cells.
    Morey AL; Patou G; Myint S; Fleming KA
    J Gen Virol; 1992 Dec; 73 ( Pt 12)():3313-7. PubMed ID: 1469369
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quantitative analysis of neutralizing immune responses to human parvovirus B19 using a novel reverse transcriptase-polymerase chain reaction-based assay.
    Bostic JR; Brown KE; Young NS; Koenig S
    J Infect Dis; 1999 Mar; 179(3):619-26. PubMed ID: 9952368
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development of an improved method of detection of infectious parvovirus B19.
    Wong S; Brown KE
    J Clin Virol; 2006 Apr; 35(4):407-13. PubMed ID: 16455300
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Detection of parvovirus B19 infection in first and second trimester fetal loss.
    de Krijger RR; van Elsacker-Niele AM; Mulder-Stapel A; Salimans MM; Dreef E; Weiland HT; van Krieken JH; Vermeij-Keers C
    Pediatr Pathol Lab Med; 1998; 18(1):23-34. PubMed ID: 9566279
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human parvovirus B19 in cord blood of premature infants.
    Koga M; Matsuoka T; Katayama K; Takeda K; Nakata M; Sase M; Kato H; Furukawa S
    Am J Perinatol; 2001 Aug; 18(5):237-40. PubMed ID: 11552176
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An assay for parvovirus B19 neutralizing antibodies based on human hepatocarcinoma cell lines.
    Caillet-Fauquet P; Di Giambattista M; Draps ML; Hougardy V; de Launoit Y; Laub R
    Transfusion; 2004 Sep; 44(9):1340-3. PubMed ID: 15318858
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sickle cell acute chest syndrome associated with parvovirus B19 infection: case series and review.
    Lowenthal EA; Wells A; Emanuel PD; Player R; Prchal JT
    Am J Hematol; 1996 Mar; 51(3):207-13. PubMed ID: 8619401
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevalence of antibodies to human parvovirus B19 nonstructural protein in persons with various clinical outcomes following B19 infection.
    Jones LP; Erdman DD; Anderson LJ
    J Infect Dis; 1999 Aug; 180(2):500-4. PubMed ID: 10395869
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Parvovirus B19 may have a role in the pathogenesis of juvenile idiopathic arthritis.
    Gonzalez B; Larrañaga C; León O; Díaz P; Miranda M; Barría M; Gaggero A
    J Rheumatol; 2007 Jun; 34(6):1336-40. PubMed ID: 17477467
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Persistence of parvovirus B19 DNA in testis of patients with testicular germ cell tumours.
    Gray A; Guillou L; Zufferey J; Rey F; Kurt AM; Jichlinski P; Leisinger HJ; Benhattar J
    J Gen Virol; 1998 Mar; 79 ( Pt 3)():573-9. PubMed ID: 9519836
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Preparation of human parvovirus B19 virus-like particles].
    Zou X; Dong L; Song J; Qu J; Yu X; Lu Z; Hong T
    Sheng Wu Gong Cheng Xue Bao; 2009 Apr; 25(4):575-9. PubMed ID: 19637634
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Frequent infection with a viral pathogen, parvovirus B19, in rheumatic diseases of childhood.
    Lehmann HW; Knöll A; Küster RM; Modrow S
    Arthritis Rheum; 2003 Jun; 48(6):1631-8. PubMed ID: 12794831
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of integrin cross-regulation in parvovirus B19 targeting.
    Weigel-Kelley KA; Yoder MC; Chen L; Srivastava A
    Hum Gene Ther; 2006 Sep; 17(9):909-20. PubMed ID: 16972759
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Variants of B19.
    Brown KE
    Dev Biol (Basel); 2004; 118():71-7. PubMed ID: 15645675
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antiphospholipid antibodies in pediatric and adult patients with rheumatic disease are associated with parvovirus B19 infection.
    Von Landenberg P; Lehmann HW; Knöll A; Dorsch S; Modrow S
    Arthritis Rheum; 2003 Jul; 48(7):1939-47. PubMed ID: 12847688
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Purification and analysis of polyhistidine-tagged human parvovirus B19 VP1 and VP2 expressed in insect cells.
    Michel PO; Mäkelä AR; Korhonen E; Toivola J; Hedman L; Söderlund-Venermo M; Hedman K; Oker-Blom C
    J Virol Methods; 2008 Sep; 152(1-2):1-5. PubMed ID: 18598721
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Generation of a parvovirus B19 vaccine candidate.
    Chandramouli S; Medina-Selby A; Coit D; Schaefer M; Spencer T; Brito LA; Zhang P; Otten G; Mandl CW; Mason PW; Dormitzer PR; Settembre EC
    Vaccine; 2013 Aug; 31(37):3872-8. PubMed ID: 23827313
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.